Clearpoint Neuro Inc
NASDAQ:CLPT

Watchlist Manager
Clearpoint Neuro Inc Logo
Clearpoint Neuro Inc
NASDAQ:CLPT
Watchlist
Price: 13.9 USD -5.12% Market Closed
Market Cap: 413.5m USD

Operating Margin

-66.2%
Current
Improving
by 11.2%
vs 3-y average of -77.4%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-66.2%
=
Operating Income
$-22.7m
/
Revenue
$34.3m

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-66.2%
=
Operating Income
$-22.7m
/
Revenue
$34.3m

Peer Comparison

Country Company Market Cap Operating
Margin
US
Clearpoint Neuro Inc
NASDAQ:CLPT
395.2m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
210.6B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
189.1B USD
Loading...
US
Stryker Corp
NYSE:SYK
137.5B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
135.2B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
126.4B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
58B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.7B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
54.9B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
48.5B USD
Loading...
US
Resmed Inc
NYSE:RMD
37B USD
Loading...
No Stocks Found

Market Distribution

Lower than 83% of companies in the United States of America
Percentile
17th
Based on 14 112 companies
17th percentile
-66.2%
Low
-4 087 900% — -5.1%
Typical Range
-5.1% — 14.8%
High
14.8% — 1 032 600%
Distribution Statistics
the United States of America
Min -4 087 900%
30th Percentile -5.1%
Median 6%
70th Percentile 14.8%
Max 1 032 600%

Clearpoint Neuro Inc
Glance View

Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 80 full-time employees. The company went IPO on 2019-07-03. The Company’s product platforms include SmartFlow Cannula and ClearPoint Navigation System Software. The SmartFlow Cannula is being utilized in approved combination product clinical and preclinical studies by pharmaceutical companies and academic research customers for various research and clinical trials in connection with delivery of therapeutic agents. The ClearPoint Navigation System Software is a software for surgical planning, navigation to target, and device delivery. The Company’s software and MRI-compatible workstation coordinate with the scanner to effectively utilize intraprocedural MR images. This provides real-time navigational instruction for the neurosurgeon to reach the desired anatomical target with a high degree of precision.

CLPT Intrinsic Value
7.64 USD
Overvaluation 45%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-66.2%
=
Operating Income
$-22.7m
/
Revenue
$34.3m
What is Clearpoint Neuro Inc's current Operating Margin?

The current Operating Margin for Clearpoint Neuro Inc is -66.2%, which is above its 3-year median of -77.4%.

How has Operating Margin changed over time?

Over the last 3 years, Clearpoint Neuro Inc’s Operating Margin has increased from -80.6% to -66.2%. During this period, it reached a low of -99.6% on Sep 30, 2023 and a high of -61.9% on Sep 30, 2024.

Back to Top